Extensive analysis of the molecular biomarkers excision repair cross complementing 1, ribonucleotide reductase M1, β-tubulin III, thymidylate synthetase, and topoisomerase IIα in breast cancer-Reference-Cited by-同舟云学术

Extensive analysis of the molecular biomarkers excision repair cross complementing 1, ribonucleotide reductase M1, β-tubulin III, thymidylate synthetase, and topoisomerase IIα in breast cancer

Published:2021-04-09 Issue:14 Volume:100 Page:e25344
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Li Juncheng,Sun Peng,Huang Tao,He Shengdong,Li Lingfan,Xue Gang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference51 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin. 2020 Jul;70(4):313];Bray;CA Cancer J Clin,2018

3. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer [published correction appears in J Clin Oncol. 2010 Jul 20;28(21):3543];Hammond;J Clin Oncol,2010

4. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;J Clin Oncol,2013

5. Chemotherapy-resistant metastatic breast cancer;Marquette;Curr Treat Options Oncol,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive and Prognostic Significance of mRNA Expression and DNA Copies Aberrations of ERCC1, RRM1, TOP1, TOP2A, TUBB3, TYMS, and GSTP1 Genes in Patients with Breast Cancer;Diagnostics;2022-02-04